A Psychedelic Molecule Controls Your Consciousness at the Moment of Death, New Theory Suggests
Some researchers believe DMT, a powerful psychedelic that may naturally occur in the brain, could be your soul’s “ferryman.” ...
European Medical Journal3d
Phase 2 trial begins for psychedelic-based depression treatment
A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.
Hosted on MSN7mon
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
VLS-01, an oral formulation of N,N-dimethyltryptamine (DMT), is designed to be administered via a buccal film applied to the lining of the cheek. This delivery method aims to induce a short ...
Researchers Uncover Intriguing Connection Between DMT, Heart Activity
DMT (N,N-Dimethyltryptamine ) is a psychedelic known for inducing intense states of consciousness. This psychedelic naturally occurs in different pla ...
Atai Life Sciences announces first patient dosed in Elumina Phase 2 trial
Life Sciences (ATAI) announced that the first patient has been dosed in the Phase 2 Elumina trial of VLS-01, atai’s proprietary oral ...
Nature3y
Psychedelic-assisted therapy: a new approach to treating depression
N-dimethyltryptamine (DMT). “Combining pharmacological and psychological intervention is a departure from existing practices so we’re treading on virgin territory,” said Small Pharma chief ...
Yahoo Finance22d
Psilera Inc. & atai Life Sciences Announce Licensing Agreement for DMT Patent Portfolio
today announced a licensing agreement (the "Agreement") under which atai has acquired Psilera's DMT (N,N-dimethyltryptamine) patent portfolio, including all granted and pending patents related to ...